Viewing StudyNCT00004163



Ignite Creation Date: 2024-05-05 @ 11:20 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004163
Status: COMPLETED
Last Update Posted: 2017-04-18
First Post: 1999-12-10

Brief Title: Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 1999-10
Start Date Type: ACTUAL
Primary Completion Date: 2001-09
Primary Completion Date Type: ACTUAL
Completion Date: 2001-09
Completion Date Type: ACTUAL
First Submit Date: 1999-12-10
First Submit QC Date: March 12 2004
Study First Post Date: 2004-03-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-04-14
Last Update Post Date: 2017-04-18
Last Update Post Date Type: ACTUAL